SK Hynix’s $26.5 billion US debut triggers a wave of leveraged ETFs on Wall Street
The South Korean memory chipmaker's Nasdaq listing has already spawned multiple 2x leveraged products, with its offering oversubscribed more than seven times
SK Hynix just pulled off one of the largest foreign listings in US exchange history, and Wall Street’s financial product factories are already running at full speed to capitalize on it.
The South Korean memory chipmaker priced its American Depositary Receipts at $149 each on Nasdaq under the ticker SKHY, raising approximately $26.5 billion. The company issued 17.79 million new shares via ADRs, representing about 2.5% of its outstanding shares.
The leveraged product gold rush
Multiple US asset managers are racing to launch or file for leveraged ETFs tied specifically to SK Hynix’s new ADRs. The ProShares Ultra SK Hynix ETF, trading under the ticker SKHU, is set to launch on July 13, 2026, targeting a 2x daily return on SKHY shares. Leverage Shares has its own 2x Long SK Hynix Daily ETF (SKHX) in the pipeline, and Direxion is filing for its Daily SK Hynix Bull 2X ETF (SKHL).
South Korea actually beat Wall Street to the punch here. Sixteen single-stock leveraged and inverse products for SK Hynix and Samsung launched in Korea on May 27, 2026.
Why the frenzy matters
SK Hynix’s US offering was oversubscribed by more than seven times, meaning for every share available, institutional investors wanted seven.
Trading for SKHY began on a when-issued basis on July 10, 2026, with regular trading expected to commence on July 13. SK Hynix filed confidentially in March 2026, announced Nasdaq as its exchange of choice in June, and was trading within weeks.
The company is the world’s leading producer of high-bandwidth memory, the specialized chips that sit inside AI accelerators. Its strategic partnership with Nvidia, which relies heavily on SK Hynix’s HBM chips for its data center GPUs, essentially makes the South Korean firm a picks-and-shovels bet on the AI boom.
What this means for investors
Leveraged ETFs are designed for daily rebalancing, not long-term holding. Compounding effects mean that a 2x leveraged product held over weeks or months can diverge significantly from twice the underlying stock’s return, particularly in volatile markets.
Three separate issuers launching nearly identical 2x products suggests a land-grab mentality. Whichever fund captures the most assets and liquidity first will likely dominate, while the others may struggle to reach critical mass. Early volume data after the July 13 launch date will be telling.